Cytology versus HPV testing for cervical cancer screening in the general population-Reference-Cited by-同舟云学术

Cytology versus HPV testing for cervical cancer screening in the general population

Published:2017-08-10 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Koliopoulos George¹,Nyaga Victoria N²,Santesso Nancy³,Bryant Andrew⁴,Martin-Hirsch Pierre PL⁵,Mustafa Reem A³,Schünemann Holger⁶,Paraskevaidis Evangelos⁷,Arbyn Marc⁸

Affiliation:

1. Elena Venizelou Maternity Hospital; Department of Obstetrics and Gynaecology; 1 Elena Venizelou Square Athens Greece 11521

2. Scientific Institute of Public Health; Unit of Cancer Epidemiology; Juliette Wytsmanstraat 14 Brussels Belgium 1050

3. McMaster University; Department of Clinical Epidemiology and Biostatistics; 1200 Main Street West Hamilton ON Canada L8N 3Z5

4. Newcastle University; Institute of Health & Society; Medical School New Build Richardson Road Newcastle upon Tyne UK NE2 4AX

5. Royal Preston Hospital, Lancashire Teaching Hospital NHS Trust; Gynaecological Oncology Unit; Sharoe Green Lane Fullwood Preston Lancashire UK PR2 9HT

6. McMaster University; Departments of Health Research Methods, Evidence, and Impact and of Medicine; 1280 Main Street West Hamilton ON Canada L8N 4K1

7. Ioannina University Hospital; Department of Obstetrics and Gynaecology; Ioannina Greece 45001

8. Sciensano; Unit of Cancer Epidemiology, Belgian Cancer Centre; Juliette Wytsmanstreet 14 Brussels Belgium B-1050

Publisher

Wiley

Subject

Pharmacology (medical)

Reference144 articles.

1. Human papillomavirus testing for primary screening in women at low risk of developing cervical cancer. The Greek experience;Agorastos;Gynecologic Oncology,2005

2. Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology;Agorastos;PLoS ONE,2015

3. Shanxi Province cervical cancer screening study II: self-sampling for high-risk human papillomavirus compared to direct sampling for human papillomavirus and liquid based cervical cytology;Belinson;International Journal of Gynecological Cancer,2003

4. SNIPER: a novel assay for human papillomavirus testing among women in Guizhou, China;Belinson;International Journal of Gynecological Cancer,2010

5. The probability for a Pap test to be abnormal is directly proportional to HPV viral load: results from a Swiss study comparing HPV testing and liquid-based cytology to detect cervical cancer precursors in 13,842 women;Bigras;British Journal of Cancer,2005

Cited by 261 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of human papillomavirus age-related prevalence and vaccination levels on interpretation of cervical screening modalities: a modelling study;BMJ Open;2024-02

2. Challenges in the diagmosis of cervical pathologies;Bulletin of Siberian Medicine;2024-01-24

3. Next-Generation Femtech: Urine-Based Cervical Cancer Diagnosis Using a Fluorescent Biothiol Probe with Controlled Smiles Rearrangement;ACS Applied Materials & Interfaces;2024-01-22

4. From Diagnosis to Treatment: Exploring the Latest Management Trends in Cervical Intraepithelial Neoplasia;Cureus;2023-12-10

5. Human papillomavirus (HPV) self-sampling to encourage the uptake of cervical screening;Cochrane Database of Systematic Reviews;2023-11-23